search
Back to results

Intraoperative Dialysis in Liver Transplantation (INCEPTION)

Primary Purpose

Liver Failure, Acute Kidney Disease, Multi-organ Failure

Status
Terminated
Phase
Not Applicable
Locations
Canada
Study Type
Interventional
Intervention
Continuous renal replacement therapy (CRRT)
Standard intraoperative support
Sponsored by
University of Alberta
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Liver Failure focused on measuring Liver transplantation (E04.210.650), Renal replacement therapy (E05.196.353), Intra-operative period (E04.614.374), Safety (N06.850.135.060.075), Efficacy

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Consent
  • Adult (age > 18 years on the day of assessment of eligibility)
  • Planned cadaveric orthotopic liver transplantation
  • Pre-operative unadjusted (natural) Modification of End-Stage Liver Disease (MELD) score > 25.
  • Pre-operative AKI, defined by a minimum RIFLE-RISK, AND/OR pre-operative estimated glomerular filtration rate (eGFR) <60 mL/min/1.73m2, calculated by the Modification of Diet in Renal Disease (MDRD) equation.

Exclusion Criteria:

  • Planned living-related donor liver transplantation
  • Pre-operative potassium [K] > 4.5 mmol/L AND urine output < 100 mL in the 6 hrs preceding assessment of eligibility
  • Pre-operative pH < 7.3

Sites / Locations

  • Division of Critical Care Medicine, University of Alberta Hospital

Arms of the Study

Arm 1

Arm 2

Arm Type

Active Comparator

Experimental

Arm Label

Standard intraoperative support (no CRRT)

Intraoperative renal support (CRRT)

Arm Description

Outcomes

Primary Outcome Measures

Number of patients adhering to the prescribed protocol
Will be defined as the proportion of patients adhering to the prescribed protocol.
Number of patients with adverse events
This will be defined by the proportion of patients experiencing intra-operative adverse events, serious adverse events and complications related to the study intervention.

Secondary Outcome Measures

Fluid balance
Will be defined as the changes in fluid accumulation intra- and post-operatively.
Number of patients with post-operative graft dysfunction
Graft dysfunction will include post-operative ultrasonographic-evidence of vascular ischemia/occlusion or venous occlusion; biliary stricture, obstruction or anastomosis leak; primary non-function; biopsy-proven rejection; or need for surgical re-exploration for any reason.
Number of patients with post-operative kidney dysfunction
Will be defined as post-operative acute kidney injury, defined by RIFLE criteria; along with encompassing receipt of renal replacement therapy (RRT).
Length of stay
Will include ICU and hospital lengths of stay
Mortality
Mortality through 90-days.
Number of patients readmitted to hospital within 90-days
Will be defined as hospital re-admission within 90-days of liver transplant for any cause.

Full Information

First Posted
March 25, 2012
Last Updated
February 4, 2017
Sponsor
University of Alberta
search

1. Study Identification

Unique Protocol Identification Number
NCT01575015
Brief Title
Intraoperative Dialysis in Liver Transplantation
Acronym
INCEPTION
Official Title
Intra-Operative Continuous Renal Replacement Therapy in Liver Transplantation: A Phase II Randomized Controlled Trial (INCEPTION)
Study Type
Interventional

2. Study Status

Record Verification Date
February 2017
Overall Recruitment Status
Terminated
Why Stopped
Insufficient funding.
Study Start Date
May 2012 (undefined)
Primary Completion Date
December 11, 2015 (Actual)
Study Completion Date
December 11, 2015 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
University of Alberta

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
Patient with liver failure waiting for liver transplantation are often hospitalized and commonly supported in an intensive care unit prior to surgery. These patients are sick, and in addition to the complications of a failing liver, other organs such as the kidneys often fail as well. As a consequence, these patients are at an increased risk for complications related to their kidney failure during their liver transplantation procedure. One potential method to diminish the risk of these complications is to provide dialysis support to these patients during their liver transplantation in the operating theater in the form of continuous renal replacement therapy (CRRT). While this is increasingly being performed and is theoretically appealing, there is very little information to support this practice. In addition, the use of CRRT during surgery is not entirely without risk. The investigators have performed two preliminary studies on the use of CRRT during liver transplantation and our data would strongly support the need to conduct further higher-quality studies to better evaluate its feasibility, safety and usefulness. Our proposed study is for a randomized trial comparing the use of CRRT during surgery with standard supportive care in sick patients with liver failure scheduled to receive a liver transplantation.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Liver Failure, Acute Kidney Disease, Multi-organ Failure
Keywords
Liver transplantation (E04.210.650), Renal replacement therapy (E05.196.353), Intra-operative period (E04.614.374), Safety (N06.850.135.060.075), Efficacy

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
32 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Standard intraoperative support (no CRRT)
Arm Type
Active Comparator
Arm Title
Intraoperative renal support (CRRT)
Arm Type
Experimental
Intervention Type
Device
Intervention Name(s)
Continuous renal replacement therapy (CRRT)
Intervention Description
Patients allocated with intraoperative CRRT will have a dialysis catheter inserted and receive CRRT during liver transplantation
Intervention Type
Procedure
Intervention Name(s)
Standard intraoperative support
Intervention Description
Patients allocated to standard intraoperative support will receive usual care (no CRRT).
Primary Outcome Measure Information:
Title
Number of patients adhering to the prescribed protocol
Description
Will be defined as the proportion of patients adhering to the prescribed protocol.
Time Frame
Intra-operative (From the induction of anesthesia to trasnfer from the OR to the ICU, average 6-8 hours)
Title
Number of patients with adverse events
Description
This will be defined by the proportion of patients experiencing intra-operative adverse events, serious adverse events and complications related to the study intervention.
Time Frame
Intra-operative (From the induction of anesthesia to trasnfer from the OR to the ICU, average 6-8 hours)
Secondary Outcome Measure Information:
Title
Fluid balance
Description
Will be defined as the changes in fluid accumulation intra- and post-operatively.
Time Frame
In-hospital (patients will be followed for duration of post-operative hospital stay, anticipated average 4 weeks post-operatively)
Title
Number of patients with post-operative graft dysfunction
Description
Graft dysfunction will include post-operative ultrasonographic-evidence of vascular ischemia/occlusion or venous occlusion; biliary stricture, obstruction or anastomosis leak; primary non-function; biopsy-proven rejection; or need for surgical re-exploration for any reason.
Time Frame
In-hospital (patients will be followed for duration of post-operative hospital stay, anticipated average 4 weeks post-operatively)
Title
Number of patients with post-operative kidney dysfunction
Description
Will be defined as post-operative acute kidney injury, defined by RIFLE criteria; along with encompassing receipt of renal replacement therapy (RRT).
Time Frame
From the date of liver transplant until the date of first documented outcome of interest, assessed until 90-days
Title
Length of stay
Description
Will include ICU and hospital lengths of stay
Time Frame
From the date of liver transplant until the date of discharge from ICU/hospital
Title
Mortality
Description
Mortality through 90-days.
Time Frame
From the date of liver transplant until the date of first documented outcome of interest, assessed until 90-days
Title
Number of patients readmitted to hospital within 90-days
Description
Will be defined as hospital re-admission within 90-days of liver transplant for any cause.
Time Frame
From the date of liver transplant after hospital discharge, until the date of first documented re-admission to hospital, assessed until 90-days

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Consent Adult (age > 18 years on the day of assessment of eligibility) Planned cadaveric orthotopic liver transplantation Pre-operative unadjusted (natural) Modification of End-Stage Liver Disease (MELD) score > 25. Pre-operative AKI, defined by a minimum RIFLE-RISK, AND/OR pre-operative estimated glomerular filtration rate (eGFR) <60 mL/min/1.73m2, calculated by the Modification of Diet in Renal Disease (MDRD) equation. Exclusion Criteria: Planned living-related donor liver transplantation Pre-operative potassium [K] > 4.5 mmol/L AND urine output < 100 mL in the 6 hrs preceding assessment of eligibility Pre-operative pH < 7.3
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Sean M Bagshaw, MD, MSc
Organizational Affiliation
Division of Critical Care Medicine, Faculty of Medicine and Dentistry, University of Alberta
Official's Role
Principal Investigator
Facility Information:
Facility Name
Division of Critical Care Medicine, University of Alberta Hospital
City
Edmonton
State/Province
Alberta
ZIP/Postal Code
T6G2B7
Country
Canada

12. IPD Sharing Statement

Citations:
PubMed Identifier
19109832
Citation
Townsend DR, Bagshaw SM, Jacka MJ, Bigam D, Cave D, Gibney RT. Intraoperative renal support during liver transplantation. Liver Transpl. 2009 Jan;15(1):73-8. doi: 10.1002/lt.21650.
Results Reference
background
PubMed Identifier
21829016
Citation
Parmar A, Bigam D, Meeberg G, Cave D, Townsend DR, Gibney RT, Bagshaw SM. An evaluation of intraoperative renal support during liver transplantation: a matched cohort study. Blood Purif. 2011;32(3):238-48. doi: 10.1159/000329485. Epub 2011 Aug 9.
Results Reference
background
PubMed Identifier
31350701
Citation
Karvellas CJ, Taylor S, Bigam D, Kneteman NM, Shapiro AMJ, Romanovsky A, Gibney RTN, Townsend DR, Meeberg G, Ozelsel T, Bishop E, Bagshaw SM. Intraoperative continuous renal replacement therapy during liver transplantation: a pilot randomized-controlled trial (INCEPTION). Can J Anaesth. 2019 Oct;66(10):1151-1161. doi: 10.1007/s12630-019-01454-0. Epub 2019 Jul 26.
Results Reference
derived

Learn more about this trial

Intraoperative Dialysis in Liver Transplantation

We'll reach out to this number within 24 hrs